Analysis of elderly patients with diffuse large B‐cell lymphoma: aggressive therapy is a reasonable approach for 'unfit' patients classified by comprehensive geriatric assessment. (6th July 2015)

• Record Type: Journal Article
• Authors: Yoshida, Masahiro; Nakao, Takafumi; Horiuchi, Mirei; Ueda, Hideya; Hagihara, Kiyoyuki; Kanashima, Hiroshi; Inoue, Takeshi; Sakamoto, Erina; Hirai, Manabu; Koh, Hideo; Nakane, Takahiko; Hino, Masayuki; Yamane, Takahisa
• Is Part Of: European journal of haematology. Volume 96:Number 4(2016:Apr.)
• Page Start: 409
• Page End: 416
• Publication Date: 2015-07-06
• Subjects: diffuse large B‐cell lymphoma -- elderly -- comprehensive geriatric assessment; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; Blood -- Periodicals; 616.15005
• DOI: 10.1111/ejh.12608
• Languages: English
• ISSNs: 0902-4441

Abstract

Abstract: Background: The treatment strategy for diffuse large B‐cell lymphoma (DLBCL) in elderly patients is problematic. Although several researchers have reported the effectiveness of comprehensive geriatric assessment (CGA) and the futility of curative treatment in 'unfit' patients with DLBCL, these propositions are not firmly established. Patients and methods: We conducted a retrospective analysis using a database. Patients with DLBCL were eligible if ≧ 60 yr old. CGA stratification was performed using medical records. Results: One hundred and 35 patients were identified. Anthracycline‐based chemotherapy with curative intent was performed in 115 (85%) patients. According to CGA, 82 (61%) patients were classified as 'fit'. Their 1‐yr overall survival (OS) was significantly better than that of 'unfit' patients [91.3% vs. 53.8%, P < 0.001]. Patients classified as 'unfit' treated with curative intent had a significantly better 1‐yr OS when compared with those receiving palliative measures [66.1% vs. 19.0%, P < 0.001]. Conclusions: CGA is an effective tool for predicting outcomes in older patients with DLBCL. The patients treated with curative intent had significantly better outcomes compared with those receiving palliation, irrespective of CGA stratification. Curative treatment should be considered even for 'unfit' patients.